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Abstract
Background: In the Northeast Indian states of Manipur and Nagaland there has been an ongoing HIV epidemic
among injecting drug users (IDUs) since the mid-1990s. Project ORCHID is an Avahan-funded HIV prevention
project that has been working in selected districts of Manipur and Nagaland since 2004. It supports local partner
non-government organisations (NGOs) to deliver a range of harm reduction interventions, and currently reaches
approximately 14,500 IDUs across the two states. To assess changes in HIV risk behaviours two Behavioural Tracking
Surveys (BTS) were undertaken among IDUs in 2007 and 2009.
Methods: The BTS used respondent driven sampling (RDS) to recruit adult male IDUs (18 years of age and above)
from Ukhrul and Chandel districts in Manipur, and Kiphire and Zunheboto districts in Nagaland. This paper reports
on analysis of socio-demographics, drug use and injecting practices, sexual behaviour and condom use, knowledge
of HIV, and exposure to interventions. Descriptive data were analysed using RDSAT, and odds ratios were
calculated in SPSS.
Results: The proportion of IDUs reporting NOT sharing needles / syringes at last injection increased substantially in
Ukhrul (59.6% to 91.2%) and Zunheboto (45.5% to 73.8%), remained high in Chandel (97.0% to 98.9%), and
remained largely unchanged in Kiphire (63.3% to 68.8%). The use of condoms with regular partners was low in all
districts at both time points. In Ukhrul, Kiphire and Zunheboto the proportion of IDUs using condoms during
sexual intercourse with a casual partner increased substantially to approximately 70-85%, whilst in Chandel the
increase was only marginal (57.4% to 63.6%). Exposure to NGO HIV prevention interventions was significantly
associated (p<0.05) with lower odds of sharing needles during the previous month (Nagaland, OR=0.63; Manipur,
OR 0.35).
Conclusion: Despite district-level differences, the results from this BTS study indicate that exposure to HIV
prevention services, predominately delivered in this region by NGOs, is associated with a reduced likelihood of
engaging in HIV risk behaviours. IDUs using HIV prevention services are more likely to engage in safe injecting and
sexual practices, and effort is required to sustain / increase opportunities for IDUs to access these services. These
outcomes are a noteworthy achievement in a very challenging context.
Background
Injecting drug users (IDUs) are at high risk of infection
with blood-borne viruses including HIV, hepatitis B and
hepatitis C, and are increasingly being targeted by poli-
cies aimed at preventing the spread of HIV [1]. Approxi-
mately 10% of HIV infections worldwide are attributable
to injecting drug use [2], and many countries in Asia,
including Thailand, Myanmar, Indonesia, Bangladesh,
Nepal and India are confronting serious HIV epidemics
among IDUs [3].
In the Northeast Indian states of Manipur and Naga-
land, approximately 2% of the population injects drugs
[4], most commonly heroin and Spasmoproxyvon (SP, a
synthetic opioid analgesic that contains dextropropoxy-
phene, dicyclomine hydrochloride and paracetamol).
Consequent to sharing of injecting equipment during
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consistently report a high HIV prevalence, and in the
case of Manipur, the highest in India. According to
2009 sentinel surveillance figures, HIV prevalence
among the general population in Manipur was 1.4%,
and in Nagaland was 0.8% [5]. Among IDUs, HIV preva-
lence was 29% in Manipur (2008) and 1.9% in Nagaland
(2007) [6]. An Integrated Biological and Behavioural
Assessment (IBBA) conducted in 2006 in Manipur and
Nagaland reported comparable HIV prevalence figures
(23.1% and 32.3% in Bishnupur and Churachandpur in
Manipur, and 1.1% and 1.8% in Phek and Wokha in
Nagaland) [7]. The prevalence of hepatitis C infection
was very high in Manipur (56% in Bishnupur and 78%
in Churachandpur), but lower in Nagaland (5.4% in
Phek and 16.7% in Wokha). The IBBA study also found
widespread sharing of injecting equipment with between
35% and 70% of IDUs reporting that they sometimes
engaged in receptive sharing of needles and syringes.
Northeast India is an ethnically distinct and geogra-
phically isolated part of the country characterised by a
longstanding civil insurgent struggle, poverty and unem-
ployment. Many communities are located in geographi-
cally difficult-to-reach areas. The response to HIV and
injecting drug use in this geo-politically complex envir-
onment was historically punitive and coercive, but a
harm reduction approach has been government policy
since the mid 1990s [8]. This currently includes provi-
sion of needle and syringe exchange programs, condom
distribution, opioid substitution therapy (recently evalu-
ated [9]), treatment for sexually transmitted infections
(STIs), and behaviour change communication.
The HIV prevention response in these two states is
coordinated by the government through the National
AIDS Control Organization (NACO) and the respective
State AIDS Control Societies (SACS). Alongside this,
Avahan (Bill & Melinda Gates Foundation in India) has
f u n d e dP r o j e c tO R C H I Dt op r o v i d eH I Vp r e v e n t i o n
interventions in selected districts of Manipur and Naga-
land over a ten year period (2004-13) [10]. Project
ORCHID is a partnership of the Emmanuel Hospital
Association, New Delhi, India and the Australian Inter-
national Health Institute, University of Melbourne, Aus-
tralia. Regardless of funding source, most of the targeted
HIV prevention interventions in Manipur and Nagaland
are delivered in the field by local non-government orga-
nizations (NGOs).
To assess changes in HIV risk behaviours two Beha-
vioural Tracking Surveys (BTS) were undertaken among
IDUs in 2007 and 2009. This paper reports on the com-
parison between baseline (2007) and follow-up (2009)
BTS data obtained from IDUs in two districts of
Manipur (Ukhrul and Chandel) and two districts of
Nagaland (Kiphire and Zunheboto) where Project
ORCHID NGOs are operational. The objectives are: 1)
to quantify changes over time with respect to the char-
acteristics of injecting drug users, HIV risk behaviours,
awareness of HIV, and exposure to harm reduction
interventions, and 2) to estimate associations between
exposure to interventions and needle sharing, condom
usage and participation in HIV testing.
Methods
Study design
The BTS is a cross-sectional survey that collects beha-
vioural data via an interviewer-administered question-
naire, which was repeated at two different time points
(2007 and 2009) in two districts of Manipur and two
districts of Nagaland. Ethics approval for this study was
obtained from the Institutional Review Board of the
Emmanuel Hospital Association Research Ethics Com-
mittee, New Delhi.
Sampling method
Respondent driven sampling (RDS) was used to recruit
IDUs for participation in the BTS. RDS is a validated
probability sampling method devised for use with hid-
den populations such as sex workers, men who have sex
with men, and IDUs, [11] that is based on social net-
work theory and builds on conventional snowball sam-
pling. RDS has previously been used to recruit
participants in many HIV biological and behavioural
surveillance studies [12]. It uses peer networks for
recruitment of participants and involves payment of
purposively recruited ‘seed’ participants, who then refer
other participants. RDS data are analysed using RDSAT
software that generates appropriately weighted estimated
proportions with confidence intervals [11,13]. The
weights are designed to account for patterns of recruit-
ment. For this study, a sample size of 400 was estimated
based on an ability to detect changes in proportions of
15% at follow-up surveys from estimated baseline values
of 50% (which yield the biggest sample size), an alpha
level of 0.05 for a two-sided test, and a power of 90%. A
design effect of 1.5 was applied to account for intra-
class correlation [14].
Data collection
Participants responded to an extensive interviewer-
administered questionnaire that was adapted from the
one used in the previously mentioned IBBA study
undertaken among high risk groups in India [7,15]. This
questionnaire has been well-described elsewhere [16].
The adapted BTS questionnaire gathered information on
socio-demographics, drug use and injecting practices,
sexual behaviour and condom use, knowledge of HIV,
and exposure to interventions. Field pre-testing of the
questionnaire was undertaken prior to baseline
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managers and screeners were provided with training to
effectively undertake their respective roles.
To be eligible to participate in the study IDUs needed
to be 18 years of age or older, and have injected drugs
for non-medical purposes at least once within the last
six months. Screeners with good knowledge of the local
injecting drug use context were employed to ensure par-
ticipants met the eligibility criteria. To start the RDS
sampling chain, four seeds in each of the districts were
purposively selected to reflect a diversity of demographic
characteristics, particularly; age, drug use pattern, geo-
graphical location, marital status and employment sta-
tus. Each seed was provided with three coded coupons
to distribute to the participants they recruited, and each
subsequent participant was also handed three coded
coupons to distribute amongst their peers. This process
continues in waves until the desired sample size is
attained. This approach potentially results in recruit-
ment of IDUs who attend Project ORCHID NGO ser-
vices, those who attend non-Project ORCHID services,
and those who do not use any services.
Statistical analysis
Data were entered using CSPro Software and transferred
to SPSS and Excel for cleaning and variable construc-
tion. Descriptive analysis was undertaken using RDSAT
(version 6.0) to generate adjusted proportion estimates
with 95% confidence intervals. Logistic regression ana-
lyses were conducted using SPSS version 18.0 to esti-
mate the strength of association between exposure to
interventions and needle sharing, condom usage and
HIV testing; the data for this analysis are grouped at the
state (rather than district) level. Odds ratios are pre-
sented with their respective 95% confidence intervals
and are adjusted for the following variables; district, age,
ever been married, literacy, age at initiation into inject-
ing drug use, most commonly used drug, and frequency
of drug use during the previous week. These adjusted
odds ratios were derived from unweighted estimates.
Unfortunately there is no consensus among statisticians
as to whether data gathered through RDS can be appro-
priately weighted for multivariate analysis, and we
encourage policy planners to interpret these regression
findings with some caution [17].
Results
Participant characteristics
The desired minimum sample size of 400 was achieved
through RDS in all four districts at both baseline and
follow-up. Some of the participants recruited at follow-
up reported participating in the baseline survey; 13.3%
(n=56) in Ukhrul, 22.9% (n=95) in Chandel, 29.7%
(n=127) in Kiphire, and 28.1% (n=126) in Zunheboto.
The characteristics of IDU participants did not change
substantially between round 1 and round 2 except with
respect to age (Table 1). The sample was predominantly
under the age of 35 years in all four districts at both
time points. At baseline and follow-up a large propor-
tion of participants were under 25 years of age in Ukh-
rul (65.5% and 41.2%), Kiphire (84.1% and 61.0%), and
Zunheboto (61.4% and 45.8%). However, the proportion
of those aged under 25 years had fallen in these districts
indicating a moderately older profile among the partici-
pants at follow-up.
Across all four districts a relatively small proportion of
participants were employed, and the majority were literate
and sexually experienced. In Ukhrul, Kiphire and Zunhe-
boto most had been married, whereas in Chandel only
approximately half had been married. The most com-
monly used drug in Manipur was heroin, whilst in Naga-
land the most commonly used drug was Spasmoproxyvon.
More than two-thirds reported first injecting drugs for
non-medical purposes when they were under the age of 25
years in Ukhrul, Kiphire and Zunheboto; approximately
half were under the age of 25 years in Chandel.
HIV risk behaviours
Manipur
In Manipur (Table 2), the proportion of IDUs reporting
that they injected at least once daily increased in Ukhrul
(36.2% to 58.1%) and decreased in Chandel (96.1% to
75.6%). There was a large improvement in safe injecting
practices in Ukhrul evidenced by a substantial increase
in the proportion of IDUs that did not share needles
with anyone during the past month (59.6% to 91.2%) or
at the last injection (71.1% to 97.0%). Additionally, there
was a decrease in the proportion of IDUs that drew up
drug solutions from a common container at last injec-
tion (26.0% to 10.3%), or used to but had stopped (5.6%
to 16.9%), between baseline and follow-up. In Chandel,
very few IDUs reported sharing needles at last injection
and during the past month at both baseline and follow-
up, however, there was an increase in the proportion
having drawn up drug solutions from common contain-
ers at last injection (6.6% to 24.6%). The majority of
IDUs in Ukhrul and Chandel had between 1 and 3
female sexual partners in the 12 months preceding both
baseline and follow-up questionnaires. The proportion
of IDUs using condoms at last sex was higher with
casual partners than with regular partners in both
Manipur districts. There was little change in the propor-
tion of IDUs using condoms at last sex, except in Ukh-
rul where a greater proportion using condoms with
casual partners at follow-up (60.2% to 80.7%). The pro-
portion of IDUs self-reporting STI symptoms decreased
in Ukhrul (37.3% to 21.3%) and increased in Chandel
(8.0% to 16.4%).
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In Nagaland (Table 2), the proportion of IDUs injecting
at least once daily decreased in Kiphire (43.0% to 28.8%)
and Zunheboto (36.6% to 26.7%). Mixed results were
obtained with respect to changes in the practice of shar-
ing needles / syringes. In Zunheboto, the proportion of
IDUs that did not share at the last injection increased
substantially (45.5% to 73.8%), while the proportion
sharing at least once during the past month remained
largely unchanged (68.7% to 72.0%). In Kiphire, the pro-
portion of IDUs that did not share needles in the past
month decreased from 85.4% to 64.1%, whilst the pro-
portion not sharing needles at the last injection
remained largely unchanged (63.3% to 68.8%). There
was a modest increase in the proportion drawing up
drug solutions from common containers at last injection
in both Kiphire (30.7% to 46.8%) and Zunheboto (41.3%
to 53.8%). Very few IDUs in Kiphire and Zunheboto had
no female sexual partners in the 12 months preceding
both baseline and follow-up questionnaires; approxi-
mately one third had between 2 and 3 sexual partners.
A greater proportion of IDUs used condoms with casual
partners at last sex at follow-up in both Kiphire (44.6%
to 73.6%) and Zunheboto (44.9% to 86.0%). However,
there was a decrease in the proportion using condoms
with regular partners at last sex in both Kiphire (47.3%
to 38.1%) and Zunheboto (52.4% to 33.4%). The propor-
tion of IDUs self-reporting STI symptoms decreased in
Zunheboto (21.1% to 11.4%) and increased in Kiphire
(9.5% to 19.4%).
Exposure to interventions and knowledge of HIV
Table 3 presents indicators of exposure to interventions
and awareness of HIV. The general overall trend was an
increase in IDUs accessing NGO services and a greater
awareness of HIV, although some district level variation
was evident. The proportion of IDUs accessing NGO ser-
vices during the previous 6 months increased substan-
tially in Ukhrul (43.2% to 81.8%) and Kiphire (54.7% to
76.6%), remained high in Chandel (84.5% to 84.4%), and
did not improve in Zunheboto (56.2% to 61.5%). There
was an increase in IDUs registering with ORCHID NGOs
Table 1 Socio-demographic profile
Manipur Nagaland
Ukhrul Chandel Kiphire Zunheboto
(%) (%) (%) (%)
2007 2009 2007 2009 2007 2009 2007 2009
N (All respondents) 421 421 420 415 417 427 422 449
Age
18-24
25-34
35+
65.5
26.1
8.3
41.2
42.3
16.3
23.8
53.9
22.1
26.5
46.9
26.5
84.1
13.1
2.8
61.0
36.3
2.6
61.4
30.3
8.3
45.8
43.6
10.4
Literacy
Cannot read and write
Can read only
Can read and write
0.2
1.9
97.7
6.4
3.2
90.3
25.9
2.2
71.7
6.1
1.7
88.6
34.0
4.3
61.6
12.8
9.0
78.1
24.7
3.3
71.9
19.3
13.1
67.5
Occupation
Unemployed
Student
Employed
Other
a
55.4
24
6.2
14.4
42.6
8.1
13.0
36.1
14.9
4.4
21.5
58.9
23.1
8.4
25.2
43.2
26.9
26.4
10.2
35.4
37.2
19.2
19.2
24.2
58.9
7.1
11.9
22.1
63.4
13.3
12.3
10.6
Ever been married
Yes
No
16.0
83.9
27.1
72.8
49.8
50.1
49.8
48.8
19.4
80.6
24.6
75.3
13.1
86.6
29.5
70.4
Age at first injection
Younger than 18
18-24
25-34
35 or older
23.3
68.7
7.3
0.6
27.8
69.1
1.2
2.1
3.4
49.2
36.7
10.8
2.4
49.3
35.8
12.5
19.6
75.8
4.6
0.0
8.7
75.0
16.3
0.0
13.8
64.3
19.0
2.9
1.2
70.5
25.3
3.0
Two most commonly used drugs
b
Heroin
SP
77.0
77.3
86.1
25.9
97.9
9.2
96.2
8.9
11.1
99.2
44.4
98.4
–
–
8.6
97.0
Ever had sexual intercourse
Yes
No
81.1
18.5
89.9
10.1
75.0
24.9
83.8
16.1
82.7
17.3
86.6
13.3
71.5
28.4
90.2
9.7
a Other category includes agricultural, small time business, and unskilled labour.
b Multiple responses allowed.
– Data unavailable for analysis.
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and Chandel (26.3% to 70.9%), but minimal changes in
the Nagaland districts of Kiphire (21.1% to 29.7%) and
Zunheboto (48.5% to 39.8%). A larger proportion of
IDUs reported usually obtaining needles from the needle
and syringe program (NSP) at follow-up in both Ukhrul
(27.4% to 67.6%) and Kiphire (38.0% to 71.0%), whilst the
proportion remained relatively high in Chandel (86.5% to
68.0%), and there was little improvement in Zunheboto
(36.5% to 35.9%). The proportion of IDUs who personally
knew someone with HIV increased in Ukhrul (76.1% to
94.1%), Chandel (37.8% to 63.0%), and Kiphire (11.3% to
38.4%), and decreased in Zunheboto (23.3% to 6.0%).
There was a reduction in the proportion of IDUs rating
themselves at no risk of getting HIV infection in all four
districts; Ukhrul (28.3% to 17.9%), Chandel (34.6% to
26.3%), Kiphire (31.0% to 4.9%) and Zunheboto 23.0% to
9.7%). A greater proportion of IDUs reported having had
an HIV test at follow-up in Ukhrul (20.2% to 41.1%),
Kiphire (10.6% to 52.0%) and Zunheboto (23.2% to
51.9%), and remained much the same in Chandel (41.9%
to 45.8%).
Table 2 Profile of injecting drug use and sexual practices
Manipur
Ukhrul Chandel
Baseline
% (95% CI)
Follow-up
% (95% CI)
Baseline
% (95% CI)
Follow-up
% (95% CI)
Frequency of injecting in the last week
At least once daily
4-6 times a week
2-3 times a week
Only once
Don’t know / remember
36.2 (29.2 – 43.0)
17.7 (12.8 – 22.0)
34.0 (27.8 – 39.4)
10.9 (7.3 – 17.4)
1.2 (0.3 – 2.6)
58.1 (0.50 – 65.9)
10.7 (6.6 – 16.0)
18.2 (12.6 – 25.1)
12.6 (7.6 – 17.4)
0.3 (0.1 – 0.7)
96.1 (93.5 – 97.7)
0.7 (0.2 – 1.4)
1.5 (0.6 – 2.9)
1.8 (0.7 – 3.1)
–
75.6 (70.1 – 81.0)
5.4 (3.4 – 7.7)
8.5 (5.4 – 12.0)
10.5 (6.4 – 14.3)
–
Did NOT share needles / syringes during past month 59.6 (53.6 - 65.2) 91.2 (88.0 – 94.0) 96.3 (94.2 – 98.0) 95.3 (92.7 – 97.5)
Did NOT share needles / syringes at last injection 71.1 (66.4 – 76.0) 97.0 (95.1 – 98.2) 97.0 (95.4 – 98.4) 98.9 (97.9 – 99.7)
Drew up drug solutions from a common container at last injection 26.0 (22.1 – 30.9) 10.3 (6.9 – 13.9) 6.6 (4.5 – 8.8) 24.6 (19.1 – 29.9)
Number of female partners had sex with in the past 12 months
None
1
2-3
>3
3.8 (1.6 – 6.5)
34.4 (28.9 – 41.7)
37.3 (31.1 – 43.1)
24.5 (19.5 – 28.9)
12.7 (8.7 – 19.0)
40.3 (32.3 – 45.5)
22.5 (17.4 – 29.0)
24.5 (19.1 – 30.9)
9.6 (6.4 – 13.1)
73.6 (66.7 – 78.1)
11.6 (8.3 – 16.4)
5.2 (2.8 – 8.8)
20.3 (16.7 – 25.9)
67.0 (60.9 – 72.3)
11.6 (7.3 – 15.2)
1.1 (0.4 – 1.9)
Condom use at last sex
Regular partner
Casual partner
40.5 (29.0 – 44.2)
60.2 (55.9 – 72.2)
48.0 (36.4 – 57.4)
80.7 (67.9 – 87.1)
34.7 (23.5 – 45.7)
57.4 (37.3 – 77.1)
27.4 (18.6 – 34.2)
63.6 (51.5 – 85.6)
STI symptoms during past 12 months 37.3 (32.5 – 41.9) 21.3 (16.4 – 25.8) 8.0 (5.8 – 10.6) 16.4 (12.5 – 20.5)
Nagaland
Kiphire Zunheboto
Baseline
% (95% CI)
Follow-up
% (95% CI)
Baseline
% (95% CI)
Follow-up
% (95% CI)
Frequency of injecting in the last week
At least once daily
4-6 times a week
2-3 times a week
Only once
Don’t know / remember
43.0 (38.5 – 51.9)
28.0 (22.1 – 32.8)
22.7 (17.3 – 26.4)
5.6 (2.4 – 8.4)
–
28.8 (22.8 – 33.1)
24.6 (18.8 – 29.3)
33.7 (28.7 – 41.8)
12.9 (8.2 – 18.6)
–
36.6 (29.3 – 43.4)
30.6 (24.1 – 36.2)
32.1 (26.4 – 40.2)
0.7 (0.0 – 1.7)
–
26.7 (20.7 – 33.9)
52.0 (45.7 – 59.0)
13.6 (10.6 – 17.8)
7.0 (3.6 – 8.2)
0.7 (0.0 – 1.5)
Did NOT share needles / syringes during past month 85.4 (81.7 – 94.0) 64.1 (59.1 – 68.8) 68.7 (61.6 – 75.1) 72.0 (66.8 – 76.6)
fDid NOT share needles / syringes at last injection 63.3 (18.3 – 87.7) 68.8 (63.7 – 73.5) 45.5 (30.7 – 50.8) 73.8 (68.6 – 78.3)
Drew up drug solutions from a common container at last injection 30.7 (26.8 – 35.1) 46.8 (40.9 – 52.8) 41.3 (35.9 – 45.5) 53.8 (47.9 – 59.1)
Number of female partners had sex with in the past 12 months
None
1
2-3
>3
3.5 (1.9 – 6.0)
45.6 (39.9 – 51.3)
33.2 (27.3 – 38.0)
17.7 (14.6 – 21.3)
0.0 (0.0 – 0.0)
38.1 (24.9 – 36.6)
31.0 (24.9 – 36.6)
30.9 (25.4 – 37.0)
3.7 (1.8 – 5.1)
42.7 (32.8 – 47.1)
27.5 (22.3 – 33.4)
26.1 (23.7 – 34.6)
0.3 (0.0 – 0.06)
54.2 (50.1 – 61.8)
29.7 (24.7 – 36.1)
15.8 (10.2 – 17.3)
Condom use at last sex
Regular partner
Casual partner
47.3 (41.2 – 58.3)
44.6 (36.7 – 57.2)
38.1 (31.1 – 46.2)
73.6 (64.2 – 83.2)
52.4 (47.2 – 61.5)
44.9 (17.1 – 64.6)
33.4 (27.0 – 41.0)
86.0 (73.8 – 90.2)
STI symptoms during past 12 months 9.5 (7.3 – 12.5) 19.4 (15.5 – 23.4) 21.1 (17.2 – 26.0) 11.4 (8.7 – 14.8)
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risk behaviours of IDUs
Analyses were conducted on follow-up data at state level
to estimate the strength of association between exposure
to interventions and: needle sharing, condom usage and
H I Vt e s t i n g .O d d sr a t i o sp r e s e n t e di nT a b l e4w e r e
adjusted for district, age, having ever been married, lit-
eracy, age at initiation into injecting drug use, most
commonly used drug, and frequency of drug use during
the previous week.
Evidence supporting an association between program
exposure and: reduced needle sharing, increased con-
dom use, and increased HIV testing emerged.
In Nagaland, registration with an ORCHID NGO was
significantly associated (p<0.05) with: lower odds of shar-
ing needles during the previous month (OR=0.63) and at
the last injection (OR=0.57); and higher odds of condom
use during the last sexual encounter with regular part-
ners (OR=1.87). Similarly, accessing NGO services in the
last six months and usually obtaining needles from the
needle and syringe program was associated with: reduced
odds of sharing needles at the last injection (OR=0.53
and 0.67 respectively); and higher odds of using a
condom at last sex with a casual partner (OR=3.98 and
2.75 respectively). Participation in HIV testing was unaf-
fected by program exposure in Nagaland.
In Manipur, registration with an ORCHID NGO was
significantly associated with higher odds of condom use
during the last sexual encounter with a regular partner
(OR=2.75). Having accessed NGO services in the last 6
months was associated with: lower odds of sharing nee-
dles during the previous month (OR=0.35); and higher
odds of condom use at last sex with a regular partner
(OR=3.00). Additionally, usually obtaining needles from
the needle syringe program was associated with: lower
odds of sharing needles during the past month
( O R = 0 . 3 2 ) ;a n dh i g h e ro d d so fc o n d o mu s ef o rl a s ts e x
with a regular partner (2.94). In Manipur, the odds of
having had an HIV test increased for those IDUs regis-
tered with an ORCHID NGO (OR=1.49) and those
usually obtaining needles from the needle syringe pro-
gram (OR=1.62).
Discussion
While the findings from this study present a mixed pic-
ture in relation to changes in HIV risk behaviours and
Table 3 Exposure to interventions and awareness of HIV
Manipur
Ukhrul Chandel
Baseline
% (95% CI)
Follow-up
% (95% CI)
Baseline
% (95% CI)
Follow-up
% (95% CI)
Registered with an ORCHID NGO 31.7 (26.9 – 37.4) 69.5 (64.8 – 75.7) 26.3 (22.5 – 32.6) 70.9 (65.6 – 76.2)
Accessed NGO services in last 6 months 43.2 (37.9-49.3) 81.8 (76.3 – 87.2) 84.5 (80.7 – 88.7) 84.4 (79.8 – 88.8)
Usually obtain needles from needle / syringe program 27.4 (23.5 – 33.9) 67.6 (62.1 – 74.3) 86.5 (82.9 – 90.4) 68.0 (63.1 – 76.7)
Personally know someone with HIV 76.1 (71.8 – 80.3) 94.1 (91.9 – 97.6) 37.8 (33.0 – 44.8) 63.0 (57.7 – 68.0)
Rate risk of HIV infection
High
Moderate
None
Don’t know
24.9 (20.9 – 28.8)
10.8 (8.1 – 13.8)
16.9 (13.2 – 20.2)
28.3 (23.9 – 33.3)
18.6 (14.4 – 23.1)
37.8 (32.0 – 42.9)
15.9 (12.1 – 20.2)
24.4 (2.0 – 29.7)
17.9 (14.0 – 21.9)
4.0 (1.7 – 6.3)
6.0 (3.8 – 8.3)
10.6 – 7.6 – 13.1)
43.5 (38.4 – 48.8)
34.6 (29.5 – 39.4)
5.3 (3.3 – 8.3)
8.8 (6.2 – 12.0)
10.1 (7.1 – 12.7)
50.7 (45.4 – 55.8)
26.3 (21.9 – 31.7)
4.1 (1.9 – 6.8)
Ever undergone HIV test 20.2 (16.5 – 24.8) 41.1 (36.3 – 46.8) 41.9 (36.3 – 47.3) 45.8 (40.4 – 51.0)
Nagaland
Kiphire Zunheboto
Baseline
% (95% CI)
Follow-up
% (95% CI)
Baseline
% (95% CI)
Follow-up
% (95% CI)
Registered with an ORCHID NGO 21.1 (17.1 – 25.2) 29.7 (24.3 – 36.1) 48.5 (42.3 – 54.8) 39.8 (33.3 – 46.3)
Accessed NGO services in last 6 months 54.7 (48.9 – 60.9) 76.6 (71.9 – 81.1) 56.2 (50.4 – 63.0) 61.5 (56.5 – 69.3)
Usually obtain needles from needle / syringe program 38.0 (34.3 – 44.1) 71.0 (65.9 – 76.3) 36.5 (31.5 – 44.3) 35.9 (29.1 – 45.6)
Personally know someone with HIV 11.3 (8.9 – 14.7) 38.4 (33.1 – 43.2) 23.3 (19.2 – 28.7) 6.0 (3.9 – 8.6)
Rate risk of HIV infection
High
Moderate
Low
None
Don’t know
17.4 (12.0 - 21.9)
22.4 (16.9 – 27.8)
11.4 (8.3 – 17.2)
31.0 (22.7 – 37.1)
17.8 (13.3 – 24.6)
12.1 (8.9 – 15.1)
32.1 (28.0 – 37.4)
43.9 (38.9 – 48.7)
4.9 (2.8 – 7.1)
5.8 (3.5 – 8.5)
2.5 (1.2 – 4.1)
8.6 (5.7 – 10.8)
53.7 (48.7 – 59.1)
23.0 (19.5 – 27.3)
12.2 (8.5 – 15.7)
12.0 (8.7 – 15.1)
26.4 (22.8 – 30.8)
39.9 (35.3 – 45.1)
9.7 (7.2 – 12.9)
10.2 (7.2 – 12.4)
Ever undergone HIV test 10.6 (5.9 – 13.5) 52.0 (46.5 – 56.7) 23.2 (19.2 – 28.3) 51.9 (46.1 – 57.0)
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tricts of Manipur and two districts of Nagaland, the
overall trend is a positive one. Consistent associations
between exposure to NGO HIV prevention services,
including Project ORCHID services, and reduced risk of
engagement in HIV risk behaviours are clearly evident.
Additionally, exposure to interventions was associated
with increased chance of HIV testing in Manipur.
Profile of injecting drug users
An important aspect of the demographic profile is that a
substantial proportion of IDUs in all four districts were
less than 25 years of age, comparable to IBBA findings
in four other districts of Manipur and Nagaland [7].
Additionally, the majority of IDUs first injected drugs
before the age of 25 years in Ukhrul, Kiphire and Zun-
heboto; in Chandel approximately half of IDUs had first
injected at this young age. Many of these men are enter-
ing into injecting drug use during their adolescent years,
and studies have demonstrated that younger age and
earlier age of initiation into injecting are associated with
HIV infection [18-21]. This raises policy and program-
ming challenges, some of which may be sensitive in this
very conservative context. Adopting a youth and equity
lens [22,23] is important to ensure: 1) adolescents have
access to HIV prevention resources (i.e. condoms, nee-
dles, etc), 2) that drug services and sexual and reproduc-
tive health services are “youth-friendly” i.e. they engage
with and respond to the information and treatment
needs of young people, 3) that information and educa-
tion on drug use and sexual and reproductive health is
widely available to adolescents, and 4) that opportunities
to interrupt the transition to injecting drug use (e.g. life
skills programs) are explored through further research
and programming.
HIV prevention service usage
A recent (2009) document produced by a collaboration
between WHO, UNODC and UNAIDS [24], identified a
range of coverage targets and impact indicators for HIV
prevention programs working with IDUs. One coverage
indicator is the percentage of IDUs regularly reached by
N S P s .C o v e r a g ei sj u d g e dt ob eh i g hi f> 6 0 %o fI D U s
are regularly being reached by NSPs. On the basis of
this indicator, the IDUs in Ukhrul, Chandel and Kiphire
were all receiving high coverage by 2009. Even though
the proportion of IDUs attending HIV prevention ser-
vices generally increased between the two BTS rounds,
some points of concern were noted and possibly warrant
programmatic adjustment, including a decrease in the
proportion of IDUs obtaining needles from NSPs in
Chandel, and consistently poor uptake of services in
Zunheboto.
IDU participation in HIV testing is an important part
of HIV prevention. The recommended coverage target
for HIV testing among IDUs is 75% of IDUs each year
[24]. Despite marked increases in the proportion of
IDUs who had been HIV tested between the two BTS
Table 4 Association between programme exposure and HIV risk behaviours of IDUs at follow-up (2009)
Adjusted odds ratios (95% CI)
Shared needles /
syringes at last
injection
Shared needles / syringes
during the past month
Condom last sex
(regular partner)
a
Condom last sex
(casual partner)
b
HIV test
Manipur
Accessed NGO
services in last 6
months
0.51 (0.14 - 1.90) 0.35** (0.17 - 0.74) 3.00** (1.45 - 6.22) 1.19 (0.44 - 3.26) 1.52 (0.88 - 2.63)
Registered with an
ORCHID NGO
0.47 (0.16 - 1.29) 0.59 (0.32 - 1.08) 2.75*** (1.63 - 4.64) 1.49 (0.78 - 3.00) 1.49* (1.01 - 2.19)
Usually obtain
needles from NSP
0.42 (0.15 - 1.17) 0.32*** (0.18 - 0.57) 2.94*** (1.77 - 4.91) 0.66 (0.32 - 1.36) 1.62* (1.10 - 2.39)
Nagaland
Accessed NGO
services in last 6
months
0.53** (0.35 - 0.79) 0.78 (0.52 - 1.15) 1.15 (0.69 - 1.92) 3.98** (1.80 - 8.76) 1.27 (0.87 - 1.85)
Registered with an
ORCHID NGO
0.57** (0.41 - 0.87) 0. 63* (0.44 - 0.90) 1.87* (1.13 – 3.07) 1.61 (0.86 – 2.98) 0.89 (0.64 - 1.25)
Usually obtain
needles from NSP
0.67* (0.46 - 0.98) 0.96 (0.68 - 1.42) 1.35 (0.83 - 2.19) 2.75** (1.35 – 6.00) 0.77 (0.55 - 1.10)
a Only IDUs who had a regular partner were included in this analysis; 422 in Manipur, 486 in Nagaland.
b Only IDUs who had a casual partner were included in this analysis; 246 in Manipur, 313 in Nagaland.
* p<0.05, ** p<0.01, *** p<0.001.
Note: Odds ratios were adjusted for the following variables; district, age, ever been married, literacy, age at initiation into injecting drug use, most commonly
used drug, and frequency of drug use during the previous week.
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way from achieving the recommended coverage target
for HIV testing. At follow-up, only around half reported
ever having had an HIV test. The poor uptake of HIV
testing among IDUs in these states was also reported in
the IBBA study [7], and is the result of a constellation
of factors including poor health system infrastructure to
support HIV testing, geographically remote commu-
nities, and lack of perceived risk. In Chandel in 2009,
77% of IDUs judged themselves to be at no or low risk
of HIV, as did 42% in Ukhrul, 49% in Kiphire and 49%
in Zunheboto. More research is required to fully under-
stand why IDUs in Manipur and Nagaland do not parti-
cipate in HIV testing, so that programs can be designed
to encourage better uptake.
Changes in injecting behaviours of IDUs
High risk injecting behaviours were common at baseline
in Ukhrul, Kiphire, and Zunheboto, with approximately
30-50% of IDUs sharing needles at last injection. Risky
injecting behaviour has been found to be common
among IDUs in other districts of Manipur and Nagaland
[7] and elsewhere in India [25]. One of the impact indi-
cators identified in the WHO/UNODC/UNAIDS docu-
ment is an increase in the percentage of IDUs reporting
use of sterile injecting equipment the last time they
injected [24]. Based on the responses to the BTS ques-
tion about not sharing needles and syringes at the time
of last injection (a roughly equivalent indicator), an
increase to almost 100% was reported in Ukhrul and a
similarly high level of safe injecting was maintained in
Chandel. A substantial increase in the percentage of
IDUs (from 45% to 74%) reported not sharing at the
time of last injection in Zunheboto, but in Kiphire there
was no real improvement in the percentage not sharing
with their last injection – where one third of IDUs con-
sistently reported sharing at their last injection, and the
proportion sharing in the last month had increased over
time.
The proportion of IDUs drawing up drug solutions
from common containers at the time of their last injec-
tion is a major cause for concern as this is an effective
route of transmission for hepatitis C virus [31]. In three
of the four districts the proportion reporting this prac-
tice increased between the two BTS rounds (Ukhrul was
the exception), and between 10-54% of IDUs, depending
on district, reported doing this in 2009. This is particu-
larly concerning given the background prevalence of
hepatitis C infection in Manipur in particular, which
was 56% in Bishnupur and 78% in Churachandpur dis-
tricts in 2006 [7]. In a development context where treat-
ment of hepatitis C is not supported in the same way
t h a tA R Ti s ,a n dm o s tI D U sc o u l dn e v e ra f f o r dt op a y
for the treatment, hepatitis C prevention is at least as
important as HIV prevention.
Sharing injecting equipment is associated with a num-
ber of factors including the type of drug being injected,
place of injection, availability of clean injecting equip-
ment and awareness of the risks of sharing. Rhodes et al
[29] apply a broader understanding of risk to examine
the social structural production of HIV risk behaviour,
identifying the inseparability of micro, meso and macro-
level factors that shape the environment in which risk is
produced beyond a focus on the individual. Under this
paradigm risk environments are shaped by factors exter-
nal to the individual such as trade, migration, neigh-
bourhood disadvantage and transition, injecting
environments, the criminal justice system, social norms
and networks, social capital, law enforcement, and
armed conflict.
A recent study among HIV positive IDUs in Manipur
identified some important local socio-structural influ-
ences on injecting risk behaviours including inadequate
coverage of needle / syringe programs (including in pris-
ons), limited access to pharmacy-sold equipment, IDUs
avoiding carrying clean injecting equipment due to fear
of harassment by police and anti-drug groups, and with-
drawal symptoms superseding health concerns [30]. A
number of other studies have highlighted the ways in
which social networks influence the extent to which
IDUs engage in risky injecting behaviours. IDUs are
more inclined to share injecting equipment when they
are a member of a social network that is large, long-
standing and dense (meaning many ties between net-
work members), and when sharing injecting equipment
is normative and an expression of social bonding
[26,27]. These are features of many IDU groupings in
Manipur and Nagaland [28]. Further research is
required to better understand the broader socio-struc-
tural drivers of HIV risk in Manipur and Nagaland to
support interventions that create local environments
that support individual, group and community-level
changes.
Changes in sexual behaviours of IDUs
Reaching IDUs with safe sex messages is in many ways a
greater challenge for harm reduction programs than
promoting safe injecting behaviours. The WHO /
UNODC / UNAIDS document indentified an increase
in the percentage of IDUs reporting the use of a con-
dom the last time they had sex as an impact indicator
[24]. For the IDUs in this study there was overall no
real increase in the proportion reporting condom use
during the last sexual encounter with regular partners,
but an increase in the proportion using condoms in the
last sexual encounter with casual partners was evident
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the prevention of sexual transmission of HIV in drug
u s es e t t i n g si si m p o r t a n t[ 3 2 ] .T h i si sp a r t i c u l a r l yt h e
case in Nagaland where around half of the IDUs had
more than one sexual partner in the last year, and
w h e r et h e2 0 0 6I B B As t u d yh ighlighted a high syphilis
prevalence among IDUs in Nagaland (7% and 19% in
Phek and Wokha districts respectively) [7], indicating
sexual risk taking and possible co-infection of HIV and
an ulcerative STI, increasing the risk of HIV transmis-
sion to sexual partners. Further research and analysis of
behavioural data is required to more comprehensively
understand the sexual behaviours of IDUs in Northeast
India and to better appreciate the sex-related risks of
HIV transmission among this group.
Association between exposure to HIV prevention services
and HIV risk behaviours
Our state-level analysis found consistent associations
between exposure to HIV prevention services and a
reduced likelihood of sharing needles and an increased
likelihood of using condoms. Exposure to HIV preven-
tion services was also associated with increased likeli-
hood of participation in HIV testing in Manipur; there
was no similar association in Nagaland. The strength of
the full impact of the HIV prevention services on HIV
risk behaviours is difficult to gauge due to the nature of
the cross-sectional study design, but in our analysis it
appears to be substantial. In Nagaland the likelihood of
sharing needles over the past month was reduced by
approximately 40% among IDUs who were registered
with an ORCHID NGO. In Manipur, IDUs who had
NOT accessed an NGO service during the past 6
months were almost three times more likely to have
shared a needle during the past month. The likelihood
of using condoms with regular partners during the last
sexual intercourse was tripled among IDUs in Manipur
who had accessed NGO services during the past 6
months, and nearly doubled among IDUs in Nagaland
who were registered with an ORCHID NGO. These
results provide evidence of an association between expo-
sure to HIV prevention services and a reduced likeli-
hood of engaging in HIV risk behaviours.
Inter and intra-state variations
T h ef i n d i n g sf r o mt h i sB T Ss t u d yv a r i e dc o n s i d e r a b l y
between states, and between districts within states. The
patterning of HIV risk behaviours and HIV prevention
service usage in this complex setting is influenced by a
constellation of factors including the supply and types of
drugs used, awareness of risks associated with sharing
injecting equipment, the social norms among local net-
works of IDUs in relation to sharing, the effectiveness of
the NGOs offering the programs, the availability of
clean needles and syringes, the freedom to access the
NSPs without harassment from police or pressure
groups, geographical accessibility of the NSPs, and the
extent of empowerment among IDU networks.
The differences between the two states are not sur-
prising as the pattern of drug use, and the maturity of
the HIV epidemic and the response to it, are very differ-
ent when the two states are compared. Manipur IDUs
inject mainly heroin, while the Nagaland IDUs inject
mainly pharmaceuticals (especially Spasmoproxyvon or
SP). SP is often taken orally, and it is not uncommon
for SP users to move in and out of injecting depending
on the availability of the drug i.e. they are more likely to
inject at times of drug shortage (but when in an inject-
ing phase, SP users may inject up to 10 times/day).
Additionally, SP is very injurious to veins, so it is diffi-
cult to inject every day for sustained periods of time. In
contrast, dependant heroin users are much more likely
to consistently inject every day over extended periods,
even decades. As the HIV epidemic in Manipur is more
severe and long-standing compared with Nagaland, the
Manipuri NGOs are more experienced in delivering pro-
grams, and awareness of HIV is greater. Communities
are more geographically isolated in Nagaland, and the
political situation is more unstable in Manipur – and
both of these factors interfere with the delivery of HIV
prevention services. Similar types of variation are evi-
dent between districts within states as well. This sort of
complexity contributes to the variability in outcomes
observed in this study, and highlights the importance of
NGO capacity to monitor what is happening locally, and
to adjust the program accordingly.
Limitations
These study findings are subject to several limitations.
The use of RDS methods to recruit participants creates
limitations for multivariate analysis; guidelines for multi-
variate analysis of RDS data are still under development
and require validation. Despite this limitation, RDS
results in probability based estimates of various partici-
pant characteristics. Reporting of certain behaviours
may have been influenced by recall and social desirabil-
ity bias with the result that socially unacceptable beha-
viours may have been under-reported. As with all cross-
sectional study designs causal relationships can’tb e
firmly determined due to the difficulty in determining
the temporal relationship between the predictors and
the outcomes. With this study design it is hard to con-
firm that exposure to services causes a change in risk
behaviours among IDUs; it is possible that the types of
IDUs who attend services are less likely to engage in
risk behaviours. However, the multivariate analysis in
this paper highlights consistent associations between
exposure to NGO HIV prevention services, including
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ment in HIV risk behaviours. It is important to note
that socio-structural factors influence HIV risk beha-
viours and these have not been reported on in this
paper; for example, place of injection, access to clean
injecting equipment, harassment by policy and anti-drug
groups, incarceration, and poverty. Further analysis of
the BTS and other data sources is required to compre-
hensively describe the socio-structural drivers of risk
behaviours.
Conclusion
Despite district-level differences, the results from this
BTS study indicate that exposure to HIV prevention ser-
vices, predominately delivered in this region by NGOs,
is associated with a reduced likelihood of engaging in
HIV risk behaviours. IDUs using HIV prevention ser-
vices are more likely to engage in safe injecting and sex-
ual practices, and effort is required to sustain / increase
opportunities for IDUs to access these services. These
outcomes are a noteworthy achievement in a very chal-
lenging context. Programmatic adjustments are required:
1) to further increase participation in HIV testing, 2) to
deliver interventions that target the risk of sexual trans-
mission of HIV and STIs, and 3) to improve awareness
of the risk of Hepatitis C transmission associated with
drawing drug solutions from common containers.
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